89Zr-Dfosq-Olaratumab
Soft Tissue Sarcoma, Pdgfr Alpha Positive Solid Tumours
Phase I
Recruiting
89Zr-olaratumab Dosimetry in Participants With PDGFR Alpha Positive Solid Tumours and Soft Tissue Sarcoma
Apr 29, 2024
―
Standard Of Care, 177Lu-Dota-Rosopatamb
Metastatic Prostate Cancer
Phase III
Terminated
The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only
May 03, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Telix Pharmaceuticals Ltd. (TLPPF) have in its pipeline
TLPPF is currently developing the following drugs: 89Zr-Dfosq-Olaratumab, Standard Of Care, 177Lu-Dota-Rosopatamb. These drug candidates are in various stages of clinical development as the company works toward FDA approval.